Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yuncheng Zhu, Zhiguo Wu, Dongmei Zhao, Xiaohui Wu, Ruoqiao He, Zuowei Wang, Daihui Peng & Yiru Fang. (2023) Clinical Guideline (CANMAT 2016) Discordance of Medications for Patients with Major Depressive Disorder in China. Neuropsychiatric Disease and Treatment 19, pages 829-839.
Read now
Read now
Jeffrey M Witkin, Lalit K Golani & Jodi L Smith. (2023) Clinical pharmacological innovation in the treatment of depression. Expert Review of Clinical Pharmacology 16:4, pages 349-362.
Read now
Read now
Mani Yavi, Ioline D. Henter, Lawrence T Park & Carlos Zarate. (2021) Key considerations in the pharmacological management of treatment-resistant depression. Expert Opinion on Pharmacotherapy 22:17, pages 2405-2415.
Read now
Read now
Danielle S. Cha, Xinyi Luo, Juhie Ahmed, Larissa Becirovic, Rebekah H. Cha & Roger S. McIntyre. (2019) Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Review of Neurotherapeutics 19:9, pages 777-783.
Read now
Read now
Eric Filice & Samantha B. Meyer. (2018) Patterns, predictors, and outcomes of mental health service utilization among lesbians, gay men, and bisexuals: A scoping review. Journal of Gay & Lesbian Mental Health 22:2, pages 162-195.
Read now
Read now
F. X. Lamy, D. Saragoussi, M. E. Johnson, A. Guiraud-Diawara, K. T. Jørgensen, J. Y. Loze & A. Maguire. (2017) The use of adjunctive antipsychotics to treat depression in UK primary care. Current Medical Research and Opinion 33:5, pages 891-898.
Read now
Read now
John L. Beyer & Richard H. Weisler. (2016) Adjunctive brexpiprazole for the treatment of major depressive disorder. Expert Opinion on Pharmacotherapy 17:17, pages 2331-2339.
Read now
Read now
Articles from other publishers (55)
K. O. Shnaider, M. L. Maksimov & A. S. Mikheeva. (2023) Efficacy and safety of antidepressant and antipsychotic combinations in the treatment of depression. Glavvrač (Chief Medical Officer):4, pages 22-30.
Crossref
Crossref
Naoki Amada, Tsuyoshi Hirose, Mikio Suzuki, Yusuke Kakumoto, Takashi Futamura, Kenji Maeda & Tetsuro Kikuchi. (2023) Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacology Reports.
Crossref
Crossref
Jingjing Zhou, Tong Zhu, Xuequan Zhu, Britta Galling & Le Xiao. (2022) Factors associated with antipsychotic use in non-psychotic depressed patients: results from a clinical multicenter survey. BMC Psychiatry 22:1.
Crossref
Crossref
HaniH Dessoki & MohamedR Soltan. (2022) Atypical antipsychotics in major depressive disorder. Egyptian Journal of Psychiatry 43:1, pages 7.
Crossref
Crossref
Y.W. Francis Lam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
277
301
.
M. A. Novitsky, A. De Sousa, A. R. Asadullin, O. A. Gavrilyuk, A. V. Petrov & R. F. Nasyrova. (2021) Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia. Personalized Psychiatry and Neurology 1:2, pages 21-45.
Crossref
Crossref
Laila TananaAsam LatifPrasad S. NishtalaDavid TaylorTimothy F. Chen. (2021) An International Comparison of the Information in the Regulatory-Approved Drug Labeling and Prescribing Guidelines for Pediatric Depression. Journal of Child and Adolescent Psychopharmacology 31:4, pages 294-309.
Crossref
Crossref
Sara Dodić, Bojana Dunjić-Kostić, Stefan Jerotić, Nikola Lalović, Maja Ivković & Maja Pantović-Stefanović. (2021) Cariprazine in the treatment of unipolar depression: Case report. Engrami 43:1, pages 82-98.
Crossref
Crossref
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Soko Setoguchi, Brian L. Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal & Mark Olfson. (2021) Mortality Risk of Antipsychotic Augmentation for Adult Depression. FOCUS 19:1, pages 86-94.
Crossref
Crossref
Shalini Mani, Sakshi Tyagi, Km Vaishali Pal, Himanshi Jaiswal, Anvi Jain, Aaru Gulati & Manisha Singh. 2021. Free Radical Biology and Environmental Toxicity. Free Radical Biology and Environmental Toxicity
73
113
.
Anita H. Clayton, Jelena Ivkovic, Dalei Chen, Vinu George & Mary Hobart. (2020) Effect of Brexpiprazole on Prolactin and Sexual Functioning. Journal of Clinical Psychopharmacology 40:6, pages 560-567.
Crossref
Crossref
Tobias Gerhard, T. Scott Stroup, Christoph U. Correll, Soko Setoguchi, Brian L. Strom, Cecilia Huang, Zhiqiang Tan, Stephen Crystal & Mark Olfson. (2020) Mortality risk of antipsychotic augmentation for adult depression. PLOS ONE 15:9, pages e0239206.
Crossref
Crossref
Jana Lotter, Marisa Möller, Olivia Dean, Michael Berk & Brian H. Harvey. (2020) Studies on Haloperidol and Adjunctive α-Mangostin or Raw Garcinia mangostana Linn Pericarp on Bio-Behavioral Markers in an Immune-Inflammatory Model of Schizophrenia in Male Rats. Frontiers in Psychiatry 11.
Crossref
Crossref
Rawiri Keenan, Lynne Chepulis, Joanna Ly, Sally Carter, Chunhuan Lao, Muhammad Asim, Abhijit Bhat, Shivam Deo, Kee Ping Lim, Ruzaimah Mohammed, Sophie Scarlet & Ross Lawrenson. (2020) Metabolic screening in primary care for patients with schizophrenia or schizoaffective disorder and taking antipsychotic medication. Journal of Primary Health Care.
Crossref
Crossref
Gerard J. Marek, Stephen Chaney & Mark J. Benvenga. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Mariam B. Camacho, Warut D. Vijitbenjaronk & Thomas J. Anastasio. (2019) Computational Analysis of Therapeutic Neuroadaptation to Chronic Antidepressant in a Model of the Monoaminergic Neurotransmitter and Stress Hormone Systems. Frontiers in Pharmacology 10.
Crossref
Crossref
Jasmina Mallet, Philip Gorwood, Yann Le Strat & Caroline Dubertret. (2019) Major Depressive Disorder (MDD) and Schizophrenia– Addressing Unmet Needs With Partial Agonists at the D2 Receptor: A Review. International Journal of Neuropsychopharmacology 22:10, pages 651-664.
Crossref
Crossref
Min Dong, Liang-Nan Zeng, Qinge Zhang, Gabor S. Ungvari, Chee H. Ng, Helen F. K. Chiu, Tian-Mei Si, Kang Sim, Ajit Avasthi, Sandeep Grover, Mian-Yoon Chong, Kok-Yoon Chee, Shigenobu Kanba, Min-Soo Lee, Shu-Yu Yang, Pichet Udomratn, Roy A. Kallivayalil, Andi J. Tanra, Margarita M. Maramis, Winston W. Shen, Norman Sartorius, Rathi Mahendran, Chay-Hoon Tan, Naotaka Shinfuku & Yu-Tao Xiang. (2019) Concurrent antipsychotic use in older adults treated with antidepressants in Asia. Psychogeriatrics 19:4, pages 333-339.
Crossref
Crossref
Mina Rouhani & Ahmad Soleymanpour. (2019) A new selective carbon paste electrode for potentiometric analysis of olanzapine. Measurement 140, pages 472-478.
Crossref
Crossref
L. Perez-Caballero, S. Torres-Sanchez, C. Romero-López-Alberca, F. González-Saiz, J. A. Mico & Esther Berrocoso. (2019) Monoaminergic system and depression. Cell and Tissue Research 377:1, pages 107-113.
Crossref
Crossref
Mary Hobart, Peter Zhang, Aleksandar Skuban, Claudette Brewer, Nanco Hefting, Raymond Sanchez & Robert D. McQuade. (2019) A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder. Journal of Clinical Psychopharmacology 39:3, pages 203-209.
Crossref
Crossref
Michael Bauer, Nanco Hefting, Annika Lindsten, Mette Krog Josiassen & Mary Hobart. (2018) A randomised, placebo-controlled 24-week study evaluating adjunctive brexpiprazole in patients with major depressive disorder. Acta Neuropsychiatrica 31:1, pages 27-35.
Crossref
Crossref
Rajnish Mago, Andrea Fagiolini, Emmanuelle Weiller & Catherine Weiss. (2018) Understanding the emotions of patients with inadequate response to antidepressant treatments: results of an international online survey in patients with major depressive disorder. BMC Psychiatry 18:1.
Crossref
Crossref
Cho-Yin Huang, Shu-Yu Yang, Ramin Mojtabai, Shu-Ku Lin, Yan-Ling He, Mian-Yoon Chong, Gabor Ungvari, Chay-Hoon Tan, Yu-Tao Xiang, Norman Sartorius, Naotaka Shinfuku & Lian-Yu Chen. (2018) Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia. Journal of Clinical Psychopharmacology 38:6, pages 598-603.
Crossref
Crossref
Changsu Han, Sheng-Min Wang, Won-Myong Bahk, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand, Laura Mandelli, Chi-Un Pae & Alessandro Serretti. (2018) A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial. Clinical Psychopharmacology and Neuroscience 16:4, pages 469-480.
Crossref
Crossref
Sanika Rege, Sneha Sura & Rajender R. Aparasu. (2018) Atypical antipsychotic prescribing in elderly patients with depression. Research in Social and Administrative Pharmacy 14:7, pages 645-652.
Crossref
Crossref
Tomasz Zaprutko, Robert Göder, Krzysztof Kus, Wiktor Pałys, Filip Rybakowski & Elżbieta Nowakowska. (2018) The economic burden of inpatient care of depression in Poznan (Poland) and Kiel (Germany) in 2016. PLOS ONE 13:6, pages e0198890.
Crossref
Crossref
Shan Xing, Gregory S. Calip, Alex D. Leow, Shiyun Kim, Glen T. Schumock, Daniel R. Touchette & Todd A. Lee. (2018) The impact of depression medications on oral antidiabetic drug adherence in patients with diabetes and depression. Journal of Diabetes and its Complications 32:5, pages 492-500.
Crossref
Crossref
B. Galling, J. A. Vernon, A. K. Pagsberg, A. Wadhwa, E. Grudnikoff, A. J. Seidman, M. Tsoy-Podosenin, M. Poyurovsky, J. M. Kane & C. U. Correll. (2018) Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia. Acta Psychiatrica Scandinavica 137:3, pages 187-205.
Crossref
Crossref
Mariam B. Camacho & Thomas J. Anastasio. (2017) Computational Model of Antidepressant Response Heterogeneity as Multi-pathway Neuroadaptation. Frontiers in Pharmacology 8.
Crossref
Crossref
Rudranil De, Somnath Mazumder, Souvik Sarkar, Subhashis Debsharma, Asim Azhar Siddiqui, Shubhra Jyoti Saha, Chinmoy Banerjee, Shiladitya Nag, Debanjan Saha & Uday Bandyopadhyay. (2017) Acute mental stress induces mitochondrial bioenergetic crisis and hyper-fission along with aberrant mitophagy in the gut mucosa in rodent model of stress-related mucosal disease. Free Radical Biology and Medicine 113, pages 424-438.
Crossref
Crossref
Na Shin, Felicia Hill-Briggs, Susan Langan, Jennifer L. Payne, Constantine Lyketsos & Sherita Hill Golden. (2017) The association of minor and major depression with health problem-solving and diabetes self-care activities in a clinic-based population of adults with type 2 diabetes mellitus. Journal of Diabetes and its Complications 31:5, pages 880-885.
Crossref
Crossref
Sherita Hill Golden, Nina Shah, Mohammad Naqibuddin, Jennifer L. Payne, Felicia Hill-Briggs, Gary S. Wand, Nae-Yuh Wang, Susan Langan & Constantine Lyketsos. (2017) The Prevalence and Specificity of Depression Diagnosis in a Clinic-Based Population of Adults With Type 2 Diabetes Mellitus. Psychosomatics 58:1, pages 28-37.
Crossref
Crossref
Yongmin Kim, Sheng-Min Wang, Kyung-Phil Kwak, Ho-Kyoung Yoon, Chi-Un Pae, Jung-Jin Kim & Won-Myong Bahk. (2016) Amisulpride Switching in Schizophrenic Patients Who Showed Suboptimal Effect and/or Tolerability to Current Antipsychotics in a Naturalistic Setting: An Explorative Study. Clinical Psychopharmacology and Neuroscience 14:4, pages 371-377.
Crossref
Crossref
Giuseppe Di Giovanni, Dubravka Svob Strac, Montse Sole, Mercedes Unzeta, Keith F. Tipton, Dorotea Mück-Šeler, Irene Bolea, Laura Della Corte, Matea Nikolac Perkovic, Nela Pivac, Ilse J. Smolders, Anna Stasiak, Wieslawa A. Fogel & Philippe De Deurwaerdère. (2016) Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases. Frontiers in Neuroscience 10.
Crossref
Crossref
Richard H. Weisler, Ai Ota, Kana Tsuneyoshi, Pamela Perry, Emmanuelle Weiller, Ross A. Baker & David V. Sheehan. (2016) Brexpiprazole as an adjunctive treatment in young adults with major depressive disorder who are in a school or work environment. Journal of Affective Disorders 204, pages 40-47.
Crossref
Crossref
Samuel R. Weber, Allison M. Wehr & Anne-Marie Duchemin. (2016) Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings. Journal of Affective Disorders 191, pages 292-299.
Crossref
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeTae-Youn JunAshwin A PatkarPrakash S MasandChi-Un Pae. (2016) Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update. Chonnam Medical Journal 52:3, pages 159.
Crossref
Crossref
Nevena Todorović, Nada Tomanović, Peter Gass & Dragana Filipović. (2016) Olanzapine modulation of hepatic oxidative stress and inflammation in socially isolated rats. European Journal of Pharmaceutical Sciences 81, pages 94-102.
Crossref
Crossref
Bart Ellenbroek & Jiun Youn. 2016. Gene-Environment Interactions in Psychiatry. Gene-Environment Interactions in Psychiatry
173
231
.
Changsu Han, Sheng-Min Wang, Kyung-Phil Kwak, Wang-Yeon Won, HwaYoung Lee, Chia Ming Chang, Tze Chun Tang & Chi-Un Pae. (2015) Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded,prospective study. Journal of Psychiatric Research 66-67, pages 84-94.
Crossref
Crossref
Elena Dale, Benny Bang-Andersen & Connie Sánchez. (2015) Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochemical Pharmacology 95:2, pages 81-97.
Crossref
Crossref
Yi Zhou, Jun Wang, Yong He, Juan Zhou, Qian Xi, Xingbo Song, YuanXin Ye & Binwu Ying. (2014) Association Between Dopamine Beta-Hydroxylase 19-bp Insertion/Deletion Polymorphism and Major Depressive Disorder. Journal of Molecular Neuroscience 55:2, pages 367-371.
Crossref
Crossref
Changsu HanSheng-Min WangSoo-Jung LeeTae-Youn JunChi-Un Pae. (2015) Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Medical Journal 51:2, pages 66.
Crossref
Crossref
Seema M. Thekdi, Antolin Trinidad & Andrew Roth. (2014) Psychopharmacology in Cancer. Current Psychiatry Reports 17:1.
Crossref
Crossref
Vincenzo Micale, Katarina Tabiova, Jana Kucerova & Filippo Drago. 2015. Cannabinoid Modulation of Emotion, Memory, and Motivation. Cannabinoid Modulation of Emotion, Memory, and Motivation
97
129
.
Elizabeth Brunner, Mauricio Tohen, Olawale Osuntokun, John Landry & Michael E Thase. (2014) Efficacy and Safety of Olanzapine/Fluoxetine Combination vs Fluoxetine Monotherapy Following Successful Combination Therapy of Treatment-Resistant Major Depressive Disorder. Neuropsychopharmacology 39:11, pages 2549-2559.
Crossref
Crossref
Mariusz Papp, Piotr Gruca, Magdalena Lasoń-Tyburkiewicz, Nika Adham, Béla Kiss & István Gyertyán. (2014) Attenuation of anhedonia by cariprazine in the chronic mild stress model of depression. Behavioural Pharmacology 25:5 and 6, pages 567-574.
Crossref
Crossref
Changsu Han, Chi-Un Pae, Sheng-Min Wang, Soo-Jung Lee, Ashwin A. Patkar, Praksh S. Masand & Alssandro Serretti. (2014) The potential role of atypical antipsychotics for the treatment of posttraumatic stress disorder. Journal of Psychiatric Research 56, pages 72-81.
Crossref
Crossref
Wint Thu Saung, Sneha Narasimhan & Falk W. Lohoff. (2014)
Lack of influence of
DAT1
and
DRD2
gene variants on antidepressant response in generalized anxiety disorder
. Human Psychopharmacology: Clinical and Experimental 29:4, pages 316-321.
Crossref
Crossref
Xin Li, Tao Yu, Xiaoye Huang, Yanfei Cao, Xingwang Li, Baocheng Liu, Fengping Yang, Weidong Li, Xinzhi Zhao, Guoyin Feng, Xu Zhang, Zaiquan Dong, Yi Lin, Xirong Li, Lin He, Xueli Sun & Guang He. (2014) SLC17A7 Gene May Be the Indicator of Selective Serotonin Reuptake Inhibitor Treatment Response in the Chinese Han Population. Journal of Clinical Psychopharmacology 34:3, pages 331-336.
Crossref
Crossref
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae. (2014) A review of current evidence for acetyl-l-carnitine in the treatment of depression. Journal of Psychiatric Research 53, pages 30-37.
Crossref
Crossref
Changsu Han, Sheng-Min Wang, Ho-Jun Seo, Boung Chul Lee, Hong Jin Jeon, Won Kim, Kyung-Phil Kwak & Chi-Un Pae. (2014) Aripiprazole augmentation, antidepressant combination or switching therapy in patients with major depressive disorder who are partial- or non-responsive to current antidepressants: A multi-center, naturalistic study. Journal of Psychiatric Research 49, pages 75-82.
Crossref
Crossref
Ravi Kumara Guralamatta Siddappa, Chih-Wei Chang & Rong-Jie Chein. (2014) From precursor to catalyst: the involvement of [Ru(η5-Cp∗)Cl2]2 in highly branch selective allylic etherification of cinnamyl chlorides. Tetrahedron Letters 55:5, pages 1031-1035.
Crossref
Crossref
Nina Sarubin, Caroline Nothdurfter, Christian Schmotz, Anna-Maria Wimmer, Julia Trummer, Martin Lieb, Manfred Uhr, Thomas C. Baghai, Thomas C. Wetter, Markus Bühner, Rainer Rupprecht & Cornelius Schüle. (2014) Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression. Psychoneuroendocrinology 39, pages 141-151.
Crossref
Crossref